{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T14:51:13Z","timestamp":1767711073849,"version":"3.48.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-03592-y","type":"journal-article","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T12:24:25Z","timestamp":1761567865000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The correlation of DPM1 overexpression with immune infiltration and poor prognosis in hepatocellular carcinoma"],"prefix":"10.1007","volume":"16","author":[{"given":"Laiwei","family":"You","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianrong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,27]]},"reference":[{"issue":"6","key":"3592_CR1","doi-asserted-by":"publisher","first-page":"574","DOI":"10.24875\/GMM.M24000833","volume":"159","author":"N Reynoso-Noveron","year":"2023","unstructured":"Reynoso-Noveron N, Torres-Dominguez JA, Morales-Juarez L, et al. Analysis of cancer mortality in Mexico using the results of the global burden of disease 2021 study. Gac Med Mex. 2023;159(6):574\u201381. https:\/\/doi.org\/10.24875\/GMM.M24000833.","journal-title":"Gac Med Mex"},{"issue":"1","key":"3592_CR2","doi-asserted-by":"publisher","first-page":"45","DOI":"10.21037\/hbsn-21-75","volume":"12","author":"L An","year":"2023","unstructured":"An L, Zheng R, Zhang S, et al. Hepatocellular carcinoma and intrahepatic cholangiocarcinoma incidence between 2006 and 2015 in China: estimates based on data from 188 population-based cancer registries. Hepatobiliary Surg Nutr. 2023;12(1):45\u201355. https:\/\/doi.org\/10.21037\/hbsn-21-75.","journal-title":"Hepatobiliary Surg Nutr"},{"key":"3592_CR3","doi-asserted-by":"publisher","first-page":"e220004","DOI":"10.1590\/1980-549720220004","volume":"25","author":"DF Cavalcante","year":"2022","unstructured":"Cavalcante DF, Garcia EM, Farias NSO, et al. Mortality due to hepatocellular carcinoma associated with hepatitis B and C viruses in the state of Sao paulo, Brazil. Rev Bras Epidemiol. 2022;25:e220004. https:\/\/doi.org\/10.1590\/1980-549720220004.","journal-title":"Rev Bras Epidemiol"},{"issue":"1","key":"3592_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.32074\/1591-951X-227","volume":"113","author":"F Inzani","year":"2021","unstructured":"Inzani F, Rindi G. Introduction to neuroendocrine neoplasms of the digestive system: definition and classification. Pathologica. 2021;113(1):1\u20134. https:\/\/doi.org\/10.32074\/1591-951X-227.","journal-title":"Pathologica"},{"key":"3592_CR5","doi-asserted-by":"publisher","unstructured":"Gastric Cancer Group OB, Chinese Medical Association; Colorectal Cancer Professional Committee, Chinese Medical Doctor Association. [Chinese expert consensus on the application of circulating tumor cell detection in the diagnosis and treatment of gastrointestinal neoplasms (2023 edition)]. Zhonghua Wei Chang Wai Ke Za Zhi. 2023;26(11):1001\u20137. https:\/\/doi.org\/10.3760\/cma.j.cn441530-20230907-00080. Colorectal Cancer Professional Committee, Chinese Anti-Cancer Association; Gastric Cancer Professional Committee, Chinese Anti-Cancer Association; Digestive Tract Polyp and Precancerous Lesion Professional Committee, Chinese Anti-Cancer Association.","DOI":"10.3760\/cma.j.cn441530-20230907-00080"},{"issue":"1","key":"3592_CR6","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s12920-023-01561-4","volume":"16","author":"GS Li","year":"2023","unstructured":"Li GS, Huang T, Zhou HF. Gene S-phase kinase associated protein 2 is a novel prognostic marker in human neoplasms. BMC Med Genomics. 2023;16(1):128. https:\/\/doi.org\/10.1186\/s12920-023-01561-4.","journal-title":"BMC Med Genomics"},{"issue":"4","key":"3592_CR7","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S1470-2045(22)00078-X","volume":"23","author":"DJH Tan","year":"2022","unstructured":"Tan DJH, Ng CH, Lin SY, et al. Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a systematic review and meta-analysis. Lancet Oncol. 2022;23(4):521\u201330. https:\/\/doi.org\/10.1016\/S1470-2045(22)00078-X.","journal-title":"Lancet Oncol"},{"key":"3592_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/biom130305549","author":"C Yuan","year":"2023","unstructured":"Yuan C, Xie H, Chen X, Dalton HM, Viswanatha R, Brathwaite R, et al. Roles of miR-196a and miR-196b in zebrafish motor function. Biomolecules. 2023. https:\/\/doi.org\/10.3390\/biom130305549.","journal-title":"Biomolecules"},{"issue":"9","key":"3592_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1010430","volume":"18","author":"HM Dalton","year":"2022","unstructured":"Dalton HM, Viswanatha R, Brathwaite R. A genome-wide CRISPR screen identifies DPM1 as a modifier of DPAGT1 deficiency and ER stress. PLoS Genet. 2022;18(9):e1010430. https:\/\/doi.org\/10.1371\/journal.pgen.1010430.","journal-title":"PLoS Genet"},{"issue":"2","key":"3592_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.2099","volume":"11","author":"A Papi","year":"2023","unstructured":"Papi A, Zamani M, Shariati G, et al. Whole exome sequencing reveals several novel variants in congenital disorders of glycosylation and glycogen storage diseases in seven patients from Iran. Mol Genet Genomic Med. 2023;11(2):e2099. https:\/\/doi.org\/10.1002\/mgg3.2099.","journal-title":"Mol Genet Genomic Med"},{"issue":"6","key":"3592_CR11","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1111\/cge.14208","volume":"102","author":"S Nagy","year":"2022","unstructured":"Nagy S, Lau T, Alavi S, et al. A recurrent homozygous missense DPM3 variant leads to muscle and brain disease. Clin Genet. 2022;102(6):530\u20136. https:\/\/doi.org\/10.1111\/cge.14208.","journal-title":"Clin Genet"},{"issue":"5","key":"3592_CR12","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1667\/RADE-23-00160.1","volume":"201","author":"R Muhtadi","year":"2024","unstructured":"Muhtadi R, Stewart S, Bunert F, et al. PUM1 and PGK1 are favorable housekeeping genes over established biodosimetry-related housekeeping genes such as HPRT1, ITFG1, DPM1, MRPS5, 18S rRNA and others after radiation exposure. Radiat Res. 2024;201(5):487\u201398. https:\/\/doi.org\/10.1667\/RADE-23-00160.1.","journal-title":"Radiat Res"},{"issue":"6","key":"3592_CR13","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1515\/jpem-2022-0641","volume":"36","author":"M Yoldas Celik","year":"2023","unstructured":"Yoldas Celik M, Yazici H, Erdem F, et al. Unique clinical presentations and follow-up outcomes from experience with congenital disorders of glycosylation: PMM2-PGM1-DPAGT1-MPI-POMT2-B3GALNT2-DPM1-SRD5A3-CDG. J Pediatr Endocrinol Metab. 2023;36(6):530\u20138. https:\/\/doi.org\/10.1515\/jpem-2022-0641.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"3592_CR14","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.202305006","author":"M Rathod","year":"2024","unstructured":"Rathod M, Franz H, Beyersdorfer V, et al. DPM1 modulates desmosomal adhesion and epidermal differentiation through SERPINB5. J Cell Biol. 2024. https:\/\/doi.org\/10.1083\/jcb.202305006.","journal-title":"J Cell Biol"},{"issue":"4","key":"3592_CR15","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/path.2440","volume":"216","author":"F Pont\u00e9n","year":"2008","unstructured":"Pont\u00e9n F, Jirstr\u00f6m K, Uhlen M. The human protein Atlas\u2013a tool for pathology. J Pathol. 2008;216(4):387\u201393. https:\/\/doi.org\/10.1002\/path.2440.","journal-title":"J Pathol"},{"issue":"D1","key":"3592_CR16","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk D, Gable AL, Lyon D, Junge A, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47(D1):D607\u201313. https:\/\/doi.org\/10.1093\/nar\/gky1131.","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"3592_CR17","doi-asserted-by":"publisher","first-page":"W60","DOI":"10.1093\/nar\/gky311","volume":"46","author":"M Franz","year":"2018","unstructured":"Franz M, Rodriguez H, Lopes C, et al. GeneMANIA update 2018. Nucleic Acids Res. 2018;46(W1):W60\u20134. https:\/\/doi.org\/10.1093\/nar\/gky311.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"3592_CR18","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.immuni.2013.10.003","volume":"39","author":"G Bindea","year":"2013","unstructured":"Bindea G, Mlecnik B, Tosolini M, et al. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity. 2013;39(4):782\u201395. https:\/\/doi.org\/10.1016\/j.immuni.2013.10.003.","journal-title":"Immunity"},{"key":"3592_CR19","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara K, Shahmoradgoli M, Mart\u00ednez E, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4:2612. https:\/\/doi.org\/10.1038\/ncomms3612.","journal-title":"Nat Commun"},{"key":"3592_CR20","doi-asserted-by":"publisher","first-page":"609","DOI":"10.2147\/IJGM.S344858","volume":"15","author":"Y-G Wei","year":"2022","unstructured":"Wei Y-G, Yang C-K, Wei Z-L, et al. High-mobility group AT-hook 1 served as a prognosis biomarker and associated with immune infiltrate in hepatocellular carcinoma. Int J Gen Med. 2022;15:609\u201321. https:\/\/doi.org\/10.2147\/IJGM.S344858.","journal-title":"Int J Gen Med"},{"issue":"5","key":"3592_CR21","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060\u201372. https:\/\/doi.org\/10.1016\/j.cell.2012.03.042.","journal-title":"Cell"},{"issue":"6","key":"3592_CR22","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.ccell.2019.04.002","volume":"35","author":"B Hassannia","year":"2019","unstructured":"Hassannia B, Vandenabeele P, Vanden Berghe T. Targeting ferroptosis to iron out cancer. Cancer Cell. 2019;35(6):830\u201349. https:\/\/doi.org\/10.1016\/j.ccell.2019.04.002.","journal-title":"Cancer Cell"},{"issue":"3","key":"3592_CR23","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/s41401-022-00981-9","volume":"44","author":"L Zhang","year":"2023","unstructured":"Zhang L, Li X-M, Shi X-H, et al. Sorafenib triggers ferroptosis via inhibition of HBXIP\/SCD axis in hepatocellular carcinoma. Acta Pharmacol Sin. 2023;44(3):622\u201334. https:\/\/doi.org\/10.1038\/s41401-022-00981-9.","journal-title":"Acta Pharmacol Sin"},{"issue":"7","key":"3592_CR24","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1111\/cas.15378","volume":"113","author":"N Iseda","year":"2022","unstructured":"Iseda N, Itoh S, Toshida K, et al. Ferroptosis is induced by lenvatinib through fibroblast growth factor receptor-4 inhibition in hepatocellular carcinoma. Cancer Sci. 2022;113(7):2272\u201387. https:\/\/doi.org\/10.1111\/cas.15378.","journal-title":"Cancer Sci"},{"issue":"7","key":"3592_CR25","doi-asserted-by":"publisher","first-page":"101302","DOI":"10.1016\/j.isci.2020.101302","volume":"23","author":"Z Liu","year":"2020","unstructured":"Liu Z, Zhao Q, Zuo Z-X, et al. Systematic analysis of the aberrances and functional implications of ferroptosis in cancer. iScience. 2020;23(7):101302. https:\/\/doi.org\/10.1016\/j.isci.2020.101302.","journal-title":"iScience"},{"key":"3592_CR26","doi-asserted-by":"publisher","first-page":"e10307","DOI":"10.7717\/peerj.10307","volume":"8","author":"M Li","year":"2020","unstructured":"Li M, Xia S, Shi P. DPM1 expression as a potential prognostic tumor marker in hepatocellular carcinoma. PeerJ. 2020;8:e10307. https:\/\/doi.org\/10.7717\/peerj.10307.","journal-title":"PeerJ"},{"issue":"1","key":"3592_CR27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s41065-020-00127-z","volume":"157","author":"Y Chang","year":"2020","unstructured":"Chang Y, He J, Tang J, et al. Investigation of the gene co-expression network and hub genes associated with acute mountain sickness. Hereditas. 2020;157(1):13. https:\/\/doi.org\/10.1186\/s41065-020-00127-z.","journal-title":"Hereditas"},{"issue":"9","key":"3592_CR28","doi-asserted-by":"publisher","first-page":"e1010430","DOI":"10.1371\/journal.pgen.1010430","volume":"18","author":"HM Dalton","year":"2022","unstructured":"Dalton HM, Viswanatha R, Brathwaite R, et al. A genome-wide CRISPR screen identifies DPM1 as a modifier of DPAGT1 deficiency and ER stress. PLoS Genet. 2022;18(9):e1010430. https:\/\/doi.org\/10.1371\/journal.pgen.1010430.","journal-title":"PLoS Genet"},{"issue":"1","key":"3592_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01316-8","volume":"8","author":"Y Yang","year":"2023","unstructured":"Yang Y, Yan Y, Yin J, et al. O-GlcNAcylation of YTHDF2 promotes HBV-related hepatocellular carcinoma progression in an N6-methyladenosine-dependent manner. Signal Transduct Target Ther. 2023;8(1):63. https:\/\/doi.org\/10.1038\/s41392-023-01316-8.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"3592_CR30","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41420-021-00468-2","volume":"7","author":"G Zhu","year":"2021","unstructured":"Zhu G, Murshed A, Li H, et al. O-Glcnacylation enhances sensitivity to RSL3-induced ferroptosis via the YAP\/TFRC pathway in liver cancer. Cell Death Discov. 2021;7(1):83. https:\/\/doi.org\/10.1038\/s41420-021-00468-2.","journal-title":"Cell Death Discov"},{"key":"3592_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103182","volume":"73","author":"X Zhou","year":"2024","unstructured":"Zhou X, Wang Y, Li X, et al. O-GlcNAcylation regulates the stability of transferrin receptor (TFRC) to control the ferroptosis in hepatocellular carcinoma cells. Redox Biol. 2024;73:103182. https:\/\/doi.org\/10.1016\/j.redox.2024.103182.","journal-title":"Redox Biol"},{"issue":"7","key":"3592_CR32","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/nrm.2017.22","volume":"18","author":"X Yang","year":"2017","unstructured":"Yang X, Qian K. Protein O-GlcNAcylation: emerging mechanisms and functions. Nat Rev Mol Cell Biol. 2017;18(7):452\u201365. https:\/\/doi.org\/10.1038\/nrm.2017.22.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"3592_CR33","doi-asserted-by":"publisher","first-page":"3676","DOI":"10.1038\/s41467-022-31218-2","volume":"13","author":"B Wiernicki","year":"2022","unstructured":"Wiernicki B, Maschalidi S, Pinney J, et al. Cancer cells dying from ferroptosis impede dendritic cell-mediated anti-tumor immunity. Nat Commun. 2022;13(1):3676. https:\/\/doi.org\/10.1038\/s41467-022-31218-2.","journal-title":"Nat Commun"},{"key":"3592_CR34","doi-asserted-by":"publisher","unstructured":"Catanzaro E, Demuynck R, Naessens F, et al. Immunogenicity of ferroptosis in cancer: a matter of context? Trends Cancer. 2024;10(5):407\u201316. https:\/\/doi.org\/10.1016\/j.trecan.2024.01.013.","DOI":"10.1016\/j.trecan.2024.01.013"},{"key":"3592_CR35","doi-asserted-by":"publisher","unstructured":"Cai H, Ren Y, Chen S, et al. Ferroptosis and tumor immunotherapy: a promising combination therapy for tumors. Front Oncol. 2023;13:1119369. https:\/\/doi.org\/10.3389\/fonc.2023.1119369.","DOI":"10.3389\/fonc.2023.1119369"},{"key":"3592_CR36","doi-asserted-by":"publisher","unstructured":"Lausmann H, Zacharias M, Neuhann TM, et al. Case report: DPM1-CDG: novel variant with severe phenotype and literature review. Front Genet. 2022;13:889829. https:\/\/doi.org\/10.3389\/fgene.2022.889829.","DOI":"10.3389\/fgene.2022.889829"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03592-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-03592-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03592-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T14:48:08Z","timestamp":1767710888000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-03592-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,27]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3592"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-03592-y","relation":{},"ISSN":["2730-6011"],"issn-type":[{"type":"electronic","value":"2730-6011"}],"subject":[],"published":{"date-parts":[[2025,10,27]]},"assertion":[{"value":"24 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was conducted under the approval of the Ethics Committee of Gongli Hospital of Shanghai Pudong New Area, China (Approval Number: 2020SHGLH009). This study was conducted in compliance with the principles outlined in the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from all participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors have consented to publish this research.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}],"article-number":"1969"}}